MedTrace Logo

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

NCT06251323 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 119680

Last updated 2026-05-01

No results posted yet for this study

Summary

Sixteen institutions will be selected from a HRSA uniform data system and have data collected for up to 3 years. Eight institutions will begin the iPATH practice transformation during year one, the other eight institutions will begin iPATH in year two. FQHC administrators, clinicians and staff will be enrolled to participate in the iPATH transformation in their clinic and will participate in qualitative interviews. Patient HbA1c data from the clinics will be collected for comparative data analysis during each year of the study.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

iPATH implementation approach

A multi-level, multi-component, customized, standardized, technology enabled, person-centered, and team-based care practice transformation strategy.

Sponsors & Collaborators

  • Ohio State University

    collaborator OTHER

  • Harvard School of Public Health (HSPH)

    collaborator OTHER

  • Impactivo, LLC.

    collaborator UNKNOWN

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • Stanford University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2027-07-01
Completion
2028-01-31

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06251323 on ClinicalTrials.gov